Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer

This study has been completed.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

UNC Lineberger Comprehensive Cancer Center

ClinicalTrials.gov Identifier:

NCT00266097

First received: December 13, 2005

Last updated: March 5, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2011
Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)